Acerta 18
Prolonged-release tablet
registration number
51/1.2/0285
What Acerta 18 contains
Methylphenindate HCl 18 mg.
other ingredients
Tablet content: fumaric acid, hypromellose, lactose monohydrate, magnesium stearate, methacrylic acid–methyl methacrylate copolymer, colloidal anhydrous silica, triethyl citrate and talc
Tablet coating: iron oxide red (E172), iron oxide yellow (E172), part hydrolysed polyvinyl alcohol, macrogol (3350), talc and titanium dioxide (E171)
Printing ink: iron oxide black (E172), isopropyl alcohol and shellac glaze.
Therapeutic classification
N06B A04 - centrally acting sympathomimetics.